Presenters at the ACP’s annual meeting discussed a new over-the-counter birth control option, norgestrel 0.075 mg (Opill), which is less effective than other options but important for women without health insurance. The presentation highlighted the importance of counseling patients on the pill’s history, side effects, and effectiveness, as well as the need to continue using condoms for STI prevention. While Opill is not in the highest tier of effectiveness, it is a significant advancement for women without access to healthcare. The presentation emphasized the importance of informed counseling for patients considering this new birth control option.
Source link
OTC birth control ‘a tremendous advance’ in women’s health, with important caveats
